MS10 New Perspective on Molecular-Targeted Therapy MS10-1 Recent advances of molecular- targeted therapy, - overview - MS10-2 Molecular-targeted therapy against cancer using next-generation therapeutic antibody MS10-3 Role of angiogenesis in cancer and Bevacizumab (Avastin) development MS10-4 Paradigm shift in the treatment of rheumatoid arthritis brought by TNF antagonists MS10-5 HMGB1 as therapeutic molecular target and drug development MS10-6 Treatment of vascular diseases with antibody therapeutics and platform formation for developing new drugs